Mucus-producing airway epithelial cell membrane

Mucus-producing airway epithelial cell membranes, specifically those of goblet cells and mucous gland cells, act as the primary barrier and secretory interface in the respiratory tract (Fahy & Dickey, 2010, NEJM). These membranes are characterized by the presence of high-molecular-weight glycoproteins known as mucins, such as MUC5AC and MUC5B, and are essential for mucociliary clearance and innate immune defense (Boucher, 2019, J. Clin. Invest.). In pathological states like asthma, COPD, and cystic fibrosis, these membranes exhibit goblet cell hyperplasia and dysregulated ion transport, often mediated by the CFTR protein or ENaC channels, resulting in mucus hypersecretion and airway plugging (Rogers, 2007, Clin. Exp. Allergy). While the membrane itself is a complex cellular structure rather than a single molecular entity, it serves as the localized site for various therapeutic interventions. Drugs such as muscarinic antagonists (e.g., tiotropium) and CFTR modulators (e.g., ivacaftor) target specific proteins embedded within these membranes to restore normal airway hydration and reduce mucus production (Wark & McDonald, 2018, Cochrane Database Syst. Rev.).

Other names

Goblet cell membraneSecretory airway epithelial cell membraneApical membrane of airway secretory cellsAirway goblet cell surface

Modulation of membrane-bound receptors (e.g., muscarinic, beta-adrenergic) and ion channels (e.g., CFTR) to regulate the synthesis, hydration, and exocytosis of mucins.